发明名称 Imidazo bicyclic iminium compounds as antitumor agents
摘要 Compounds of formula I:; are disclosed. The compounds are inhibitors of Hedgehog pathway activation and are useful in treating solid tumors. An example of such a compound is: ;
申请公布号 US9611276(B2) 申请公布日期 2017.04.04
申请号 US201314409683 申请日期 2013.06.19
申请人 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 发明人 Chen James;Kato Tomoyo Sakata;Ondrus Alison Evelynn
分类号 C07D515/04;C07D513/04;A61K31/437;C07D471/04;C07D487/04;A61K31/4188;A61K31/429;A61K31/5383;A61K31/55;C07D498/04 主分类号 C07D515/04
代理机构 Heslin Rothenberg Farley & Mesiti, P.C. 代理人 Heslin Rothenberg Farley & Mesiti, P.C. ;Hansen Philip
主权项 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound of formula II: wherein: R1 is chosen from optionally substituted aryl and optionally substituted heteroaryl; R2a is chosen from H and (C1-C4)alkyl; R3a is chosen from optionally substituted aryl and optionally substituted heteroaryl; A1 is (a) a fused, saturated ring of 7 members that contains no heteroatoms other than the nitrogen at the point of fusion, said saturated ring optionally substituted with one or two (C1-C4)alkyl residues or (b) a fused bicycle, one ring of said fused bicycle being a saturated ring of 7 members that contains no heteroatoms other than the nitrogen at the point of fusion and a second ring of said fused bicycle being a benzene ring, said bicycle optionally substituted with one or two (C1-C4)alkyl residues; and X is any counterion.
地址 Stanford CA US